Inventiva S.A. - Ordinary shares, nominal value (euro) 0.01 per share (IVA)

Historical Holders from Q3 2020 to Q4 2025

Type / Class
Equity / Ordinary shares, nominal value (euro) 0.01 per share
Symbol
IVA on Nasdaq
Shares outstanding
182,975,595
Price per share
$4.60
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,106,787
Total reported value
$29,415,940
% of total 13F portfolios
0%
Share change
+178,728
Value change
+$1,094,859
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inventiva S.A. - Ordinary shares, nominal value (euro) 0.01 per share (IVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 11% +35% $49,037,031 +$24,518,517 14,814,813 +100% Invus Public Equities, L.P. 30 Jun 2025
Samsara BioCapital, L.P. 7.4% +25% $56,191,805 +$22,319,746 13,540,194 +66% Srinivas Akkaraju 17 Nov 2025
Andera Partners 8.8% +33% $40,700,736 +$20,350,370 12,296,295 +100% Andera Partners 30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 5% -18% $39,714,931 +$4,251,111 9,569,863 +12% BVF PARTNERS L P/IL 17 Nov 2025
New Enterprise Associates 17, L.P. 6% $31,315,238 8,350,730 New Enterprise Associates 17, L.P. 07 May 2025
Sofinnova Crossover I 7.2% $29,221,151 7,792,307 Sofinnova Crossover I SLP 31 Dec 2024
Yiheng Capital Management, L.P. 5.5% -36% $43,962,416 +$18,899,084 7,597,148 +75% Yiheng Capital Partners, L.P. 30 Sep 2025
PERCEPTIVE ADVISORS LLC 5% -14% $42,246,764 +$10,098,434 7,300,666 +31% Perceptive Advisors LLC 30 Sep 2025
Broqua Pierre 4.3% $15,365,625 4,097,500 Pierre Broqua 31 Dec 2024
As of 30 Sep 2025, Inventiva S.A. - Ordinary shares, nominal value (euro) 0.01 per share (IVA) has 15 institutional shareholders filing 13F forms. They hold 5,106,787 shares. of 182,975,595 outstanding shares (2.8%) .

Institutional Holders of Inventiva S.A. - Ordinary shares, nominal value (euro) 0.01 per share (IVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 27,550 $125,273 +$8,277 $4.60 2
2025 Q3 5,106,787 $29,415,940 +$1,094,859 $5.79 15
2025 Q2 4,928,159 $15,667,628 +$214,859 $3.19 12
2025 Q1 4,860,363 $12,214,319 -$1,721,340 $2.94 8
2024 Q4 5,447,098 $11,663,912 +$1,275,982 $2.14 7
2024 Q3 4,851,351 $9,059,439 -$1,414 $1.86 7
2024 Q2 4,845,553 $14,461,203 -$19,438 $2.99 7
2024 Q1 4,849,836 $17,555,978 -$52,773 $3.62 8
2023 Q4 4,860,874 $21,917,529 +$26,077 $4.52 8
2023 Q3 4,855,354 $20,589,732 +$102,187 $4.20 7
2023 Q2 4,830,074 $19,513,567 -$1,019,078 $4.04 8
2023 Q1 5,129,875 $18,275,932 +$1,089,878 $3.64 8
2022 Q4 4,812,252 $21,919,774 -$19,722,477 $4.44 6
2022 Q3 8,933,248 $33,067,000 -$1,003,809 $3.86 7
2022 Q2 9,109,429 $51,761,000 +$29,343,302 $5.77 10
2022 Q1 3,934,328 $45,020,000 +$2,060,118 $11.40 9
2021 Q4 3,755,787 $51,299,000 +$608,002 $13.66 10
2021 Q3 3,708,525 $52,500,000 +$30,368,738 $14.16 11
2021 Q2 1,564,469 $21,328,000 -$848,745 $13.58 14
2021 Q1 1,623,116 $23,833,940 -$15,643,566 $14.69 13
2020 Q4 2,733,996 $39,206,000 -$22,116,536 $14.50 15
2020 Q3 4,021,314 $47,498,000 +$47,498,000 $11.81 17